CFDB - Cystic Fibrosis DataBase :: Article :: Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Who Previously Discontinued Lumacaftor/Ivacaftor Due To Respiratory Adverse Events: a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study

CFDB - Cystic Fibrosis DataBase

primary studies published, non RCT

Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Who Previously Discontinued Lumacaftor/Ivacaftor Due To Respiratory Adverse Events: a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study

Year: 2019
Date: 1977
Author: Schwarz C

Keywords: Airway clearance technique; Drainage; Inhalation OR nebulised; non pharmacological intervention - devices OR physiotherapy;